Biotechnology - Montpellier, Occitanie, France
Azelead is a Contract Research Organization (CRO) and biopharmaceutical company based in Montpellier – France offering more than 20 years of expertise on the Zebrafish in vivo model.Human and Zebrafish share 70% genetic homology, 86% of drugs effects translation and highly conserved cyto-histological architectures. Using the polyvalent Zebrafish model, we perform high-content studies to ensure environmental security, safety, and efficacy of new chemical compounds with therapeutic, environmental, chemical, cosmetic, or nutritional potential.We ease hit-to-lead process using our innovative standardised or tailored protocols apply to all R&D fields: - Oncology- Infection diseases- Neurological Disorders (CNS/PNS)- Cardiovascular/Cardiomyopathies/Angiogenesis- Immune System- Rare Diseases- Hepatology- Nephrology- Dermato-Cosmetology- Predictive-Toxicology - Eco-ToxicologyWith the zebrafish alternative model, we offer earlier predictive results using a fast & cost-efficient technology within the respect of 3R's standards (Reduce, Refine, Replace – AAALAC Certified) for animal care.www.azelead.comcontact@azelead.com
Outlook
Varnish
WordPress.org
Google Font API
Microsoft Office 365